Universität zu Köln

Schostak, M., Koenig, F., Boegemann, M., Goebell, P., Hammerer, P., Machtens, S., Schwentner, C., Thomas, C., von Amsberg, G., von Rundstedt, F. -C. and Heidenreich, A. (2018). Advanced Prostate Cancer Consensus Conference 2017. Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts. Urologe, 57 (7). S. 813 - 821. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Full text not available from this repository.

Abstract

In March 2017 the aEuroeAdvanced Prostate Cancer Consensus Conference' (APCCC) took place in St. Gallen (Switzerland). The APCCC-panelists are internationally well known experts. With the actual data in mind they discussed treatment options for patients with advanced prostate cancer in order to update the international APCCC-recommendations from the previous meeting in 2015. Recently these consensus recommendations have been published in European Urology. A group of German experts discussed this year APCCC-votes during the meeting and the recommendations that were concluded from the votes from the German perspective. Reasons for an additional German discussion are country-specific variations that may have influenced the APCCC-votes und recommendations. Due to the concept of the APCCC-meeting the wording of the questions could not always be as necessary. One focus of this year consensus discussion was the treatment of metastatic castration-naive prostate cancer (mCNPC). There are new data which may also influence the therapeutic situation of patients with metastatic castration-resistant prostate cancer (mCRPC). Further points of discussion were the impact of new imaging procedures in the clinical setting as well as the treatment of oligometastatic prostate cancer.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Schostak, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Koenig, F. UNSPECIFIED UNSPECIFIED UNSPECIFIED Boegemann, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Goebell, P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Hammerer, P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Machtens, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Schwentner, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Thomas, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED von Amsberg, G. UNSPECIFIED UNSPECIFIED UNSPECIFIED von Rundstedt, F. -C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Heidenreich, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-181353
DOI:	10.1007/s00120-018-0680-9
Journal or Publication Title:	Urologe
Volume:	57
Number:	7
Page Range:	S. 813 - 821
Date:	2018
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1433-0563
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language MITOXANTRONE PLUS PREDNISONE; RADICAL PROSTATECTOMY; PHASE-III; DOCETAXEL; SURVIVAL; CABAZITAXEL; ENZALUTAMIDE; ABIRATERONE; THERAPY; DISEASE Multiple languages Urology & Nephrology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/18135